News & Press Releases – SutroVax
Foster City, CA, July 19, 2017 – SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases, today announced the appointment of Moncef Slaoui, PhD, to the company’s Board of Directors.
